Clinical Trial: A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Phase III Randomized, Double-Blind,Placebo-Controlled, Multicenter Study of Icatibant for Subcutaneous Injection in Patients With Acute Attacks of Hereditary Angioedema

Brief Summary: This study is being conducted to evaluate the efficacy and safety of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE).